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A B S T R A C T
Primary Fallopian tube carcinoma is a rare malignancy and is not often diagnosed preoperatively. We present a case
of a 67-year old woman who complained of postmenopausal vaginal bleeding. After a negative hysteroscopy, transva-
ginal ultrasound showed a well vascularized solid-cystic tumor in the adnexal region separate from the ovary. The pres-
ence of an adnexal mass was confirmed by MR imaging. Total abdominal hysterectomy with bilateral salpingoopho-
rectomy, omentectomy and appendectomy, as well as pelvic and para-aortic lymphadenectomy was performed. The
pathohistological diagnosis was poorly differentiated serous adenocarcinoma of the Fallopian tube, FIGO stage IA. The
patient was subsequently treated with platinum based adjuvant chemotherapy.
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Introduction
Primary Fallopian tube carcinoma is extremely un-
common and accounts for approximately 1% of female
genital tract malignancies1. The incidence of Fallopian
tube carcinoma is probably underestimated, as the histo-
logic appearance and clinical behavior resemble that of
primary ovarian carcinoma, and therefore many advan-
ced cases are mistakenly attributed to ovarian cancer.
Even so, the incidence of primary Fallopian tube carci-
noma has been rising during the last decades and varies
between 2.9/1,000,000 and 5.7/1,000,0002.
Fallopian tube malignancy is seldom diagnosed preop-
eratively. It mainly presents with abnormal vaginal blee-
ding, excessive vaginal discharge, abdominal pain, and a
pelvic mass. The disease has also been reported as an in-
cidental finding during surgery3. An elevation of serum
CA 125 level may herald the presence of tubal as well as
ovarian carcinoma. Rarely patients with tubal carcinoma
present in the manner of acute pelvic inflammatory
disease4,5.
Recently, ultrasonography (US) has been recommen-
ded for the preoperative detection of Fallopian tube mali-
gnancy6,7. Magnetic resonance (MR) imaging may be use-
ful to assist in the diagnosis of this rare disease8,9.
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Case Report
A 67-year-old postmenopausal woman, gravida 5, pa-
ra 3, complained of postmenopausal vaginal bleeding
lasting for two weeks.
The patient was admitted for hysteroscopy. Atrophic
endometrium with thin adhesions and areas of petechial
hemorrhage was seen and biopsy was performed (Figure
1). The pathohistologic specimen was negative for malig-
nancy. On transvaginal ultrasound (US) the uterus mea-
sured 37x26x32 mm with the endometrial layer of 1.2
mm. There was a small amount of fluid collection in the
uterine cavity. In the left adnexal region there was a
solid-cystic tumor with the solid part measuring 68x28
mm and the cystic part measuring 46x17 mm (Figure 2).
Although US demonstrated the presence of a solid mass
in the adnexal region the ovary could be seen separately.
The tumor was well vascularized with a PI of 0.41 and an
RI of 0.34.
For further investigation, MR imaging was performed
with a 1.5 Tesla superconducting unit. Sagittal and trans-
verse T2-weighted images demonstrated a circumscribed
solid-cystic adnexal mass measuring 70 mm in diameter.
Associated findings included hydrosalpinx and intraute-
rine fluid (Figure 3).
Preoperative serum cancer antigen 125 level was 301.4
U/mL (normal range 0–35 U/mL).
At surgery, a solid-cystic tumor measuring 80x60 mm
was found within the ampular part of the left Fallopian
tube with intact serosal surface (Figure 4). The left ovary
appeared normal. Frozen section revealed poorly differ-
entiated tubal carcinoma. Total abdominal hysterectomy
with bilateral salpingoophorectomy, omentectomy, ap-
pendectomy, pelvic and para-aortic lymphadenectomy was
performed. The pathohistological diagnosis was poorly
differentiated serous adenocarcinoma of the Fallopian
tube. There were no malignant cells present in perito-
neal washings, nor in the 36 pelvic and 10 para-aortic
lymph nodes evaluated. The uterus, the left ovary, the
right adnexa, the omentum and the appendix were all
free of the disease. The final diagnosis was Fallopian tube
adenocarcinoma of serous cell type, International Feder-
ation of Gynecology and Obstetrics stage IA. Platinum
based adjuvant chemotherapy was initiated on the ninth
postoperative day.
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Fig. 1. Hysteroscopy showing atrophic endometrium, thin adhe-
sions and areas of petechial hemorrhage.
Fig. 2. Transvaginal ultrasonography showing a solid-cystic tu-
mor in the left adnexal region with the solid part measuring
68x28 mm.
Fig. 3. Fallopian tube carcinoma. A sagittal T2-weighted FRSE
image. The Fallopian tube is shown as a dilated tubular struc-
ture that contains solid tumor components.
Fig. 4. Excised tumor, measuring 80x60 mm.
Discussion
The diagnosis of tubal malignancy, overall, is made
preoperatively in less than 5% of cases10. The preopera-
tive diagnosis is usually difficult, and most patients with
tubal carcinoma undergo laparotomy with the presumed
diagnosis of ovarian carcinoma according to the presence
of an adnexal mass11,12. In many cases the disease is an
incidental finding during surgery for unrelated condi-
tions.
Carcinoma of the Fallopian tube affects mainly wo-
men of 60+ years. The median age at diagnosis of 17
cases with primary Fallopian tube carcinoma evaluated
by Liapis et al. was 62 years13. At the diagnosis our pa-
tient was 67 years old.
Pain, bleeding, and discharge were once said to be the
triad characterizing the Fallopian tube carcinoma, but
abnormal vaginal bleeding has generally been reported
as the chief symptom14.
Preoperative diagnosis of tubal cancer is difficult and
the sonographic appearances of Fallopian tube malig-
nancy can be equivocal. Transvaginal US is superior to
transabdominal scan in detection of Fallopian tube ma-
lignancy. In 2004 the preoperative diagnosis of Fallopian
tube malignancy was established by the presence of an
adnexal mass with an incomplete septation on transva-
ginal US by Haratz-Rubinstein et al.6. In the majority of
published cases a cystic mass next to the normal-looking
ovary and the clinical presentation allowed to make an
accurate preoperative diagnosis. Moreover, the sonogra-
phic appearance of free fluid in the uterine cavity is as-
sumed to represent the watery vaginal discharge, which
is clinically associated with this tumor15.
Kurjak et al. and Yuen et al. used Doppler transva-
ginal ultrasonography for the diagnosis of primary Fallo-
pian tube cancer16,17. Neovascularization in tumors con-
sists of pathologic and tortuous, dilated and saccular
blood vessels. These newly formed blood vessels lack a
muscular layer in the vessel walls, which maintains a rel-
atively high resistance in normal tissues. Due to their
lack of regulatory function, these vessels may demon-
strate a continuously high diastolic flow, a smaller differ-
ence between systolic and diastolic peaks and low pulsa-
tility. Therefore low vascular impedance on Doppler US
strengthens the sonographic diagnosis. In our patient PI
of 0.41 and RI of 0.34 were present.
The use of MR imaging in the diagnostic evaluation of
pelvic disease allows an objective diagnosis and better
characterization of adnexal neoplasms18.
Due to the low incidence of the disease, there is no
consensus about therapeutic management, especially re-
garding the usefulness of extensive lymphadenectomy19.
The patterns of spread of this tumor have long been con-
sidered similar to those of epithelial ovarian cancer20. In
patients with primary tubal carcinoma, the left para-aor-
tic chain above the level of the inferior mesenteric artery
is the most frequently involved. A complete lymphade-
nectomy (including all pelvic and para-aortic chains up to
the level of the left renal vein) should be performed in pa-
tients with primary tubal carcinoma, even in patients
with stage I disease21.
Although our patient was diagnosed with FIGO stage
IA disease we decided to perform adjuvant platinum-
-based chemotherapy due to the poor differentiation of
the carcinoma. It seems that the combination of com-
plete surgical resection with adjuvant chemotherapy is
still the best option for patients with primary Fallopian
tube carcinoma. The 5-year survival rate is 56.4% and
survival per stage is now rather similar to the survival of
ovarian carcinoma22. Some authors recommend second
look laparotomy after the completion of primary thera-
py23. In patients with Fallopian tube carcinoma the ma-
jority of authors recommend platinum-based chemothe-
rapy24. Patients with recurrent Fallopian tube cancer
have limited therapeutic options. After treatment with
nanoparticle albumin-bound paclitaxel Teneriello et al.
reported the objective response rate to be 64% in the
group of patients with recurrent Fallopian tube cancer25.
In conclusion, we presented a very rare case of pri-
mary Fallopian tube malignancy in a patient with post-
menopausal bleeding after negative hysteroscopy. The di-
agnosis was established preoperatively with the use of
imaging techniques, namely transvaginal color Doppler
sonography and magnetic resonance imaging, as well as
elevated tumor marker CA 125, and confirmed by laparo-
tomy.
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PREDOPERACIJSKA DIJAGNOZA MALIGNITETA JAJOVODA S DOPLERSKIM ULTRAZVUKOM
I MAGNETSKOM REZONANCIOM, NAKON NEGATIVNOE HISTEROSKOPIJE ZBOG
POSTMENOPAUZALNOG KRVARENJA
S A @ E T A K
Primarni rak jajovoda je rijetka maligna bolest, a ~esto nije dijagnosticiran preoperativno. Prikazujemo slu~aj 67-go-
di{nje `ene koja se `alila na postmenopaualnoi vaginalno krvarenj. Nakon negativne histeroskopije, transvaginalni
ultrazvuk pokazao je dobro vaskuliziran ~vrsti cisti~ni tumor u adneksalnoj regiji zasebno od jajnika. Prisutnost adnek-
salne mase potvrdila je magnetska rezonanca. Provedena je totalna abdominalna histerektomija s bilateralnom salpin-
gofrectomijom, omentektomijom i apendektomijom, kao i zdjeli~nom i para-aortnom limfadenektomijom. Patohisto-
lo{ka dijagnoza slabo je razlikovala serozan adenokarcinom jajovoda, FIGO stadij IA. Pacijentica je nakon toga bila na
terapiji mje{anom kemoterapijom.
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